Application 761310

Type
BLA
Sponsor
IMMUNOGEN INC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001MIRVETUXIMAB SORAVTANSINEMIRVETUXIMAB SORAVTANSINEINJECTABLE;INJECTION100mg/20mL single-dose vialNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
72903-853ELAHEREmirvetuximab soravtansineImmunoGen, Inc.BLACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
77947SUPPL 2024-03-25
77921SUPPL 2024-03-22
72801ORIG2022-12-07
72617ORIG2022-11-15
72616ORIG2022-11-14